NASDAQ:ATHA
Athira Pharma
- Stock
Last Close
4.01
06/11 21:17
Market Cap
126.10M
Beta: 2.82
Volume Today
51.22K
Avg: 246.55K
PE Ratio
−1.03
PFCF: −1.30
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -5.10M - | -5.16M 1.26% | -19.95M 286.65% | -54.85M 174.88% | -95.64M 74.36% | -117.67M 23.04% | |
depreciation and amortization | 2 - | 251K 12,549,900% | 479K 90.84% | 845K 76.41% | 969K 14.67% | ||
deferred income tax | -2 - | -251K 12,549,900% | -11.85K - | ||||
stock based compensation | 196K - | 253K 29.08% | 633K 150.20% | 4.62M 630.33% | 10.61M 129.42% | 10.62M 0.16% | |
change in working capital | 245K - | 678K 176.73% | -6.45M 1,050.59% | 6.16M 195.58% | 11.94M 93.80% | 6.53M 45.33% | |
accounts receivables | -23 - | -1.30K 5,552.17% | -1.04M 79,592.31% | 1.11M 207.05% | -401K 136.16% | ||
inventory | 23 - | 1.30K 5,552.17% | 1.04M 79,592.31% | -1.11M 207.05% | |||
accounts payables | 701K - | 2.60M 271.04% | 5.15M 98.00% | 2.10M 59.20% | 7.37M 250.64% | ||
other working capital | 245K - | -23K 109.39% | -9.05M 39,230.43% | 1.01M 111.17% | 9.84M 873.96% | -439K 104.46% | |
other non cash items | 173K - | 517K 198.84% | 1.65M 219.92% | 493K 70.19% | -219K 144.42% | -1.19M 442.53% | |
net cash provided by operating activities | -4.48M - | -3.71M 17.18% | -24.11M 549.42% | -43.10M 78.73% | -72.47M 68.15% | -100.75M 39.03% | |
investments in property plant and equipment | -2.32M - | -1.57M 32.20% | -1.14M 27.46% | -304K 73.36% | |||
acquisitions net | 2.51K - | -58.80K 2,446.57% | -95.39M 162,119.20% | ||||
purchases of investments | -5.25M - | -995K 81.05% | -226.84M 22,697.69% | -299.20M 31.90% | -95.29M 68.15% | -27.67M 70.96% | |
sales maturities of investments | 7.25M - | 2.50M 65.59% | 19.05M 663.65% | 296.69M 1,457.19% | 154.09M 48.06% | 123.06M 20.14% | |
other investing activites | 7K - | 6K 14.29% | 36K 500% | -2.51K 106.96% | 58.80K 2,446.57% | 95.39M 162,119.20% | |
net cash used for investing activites | 2.01M - | 1.51M 24.96% | -210.07M 14,048.74% | -4.08M 98.06% | 57.66M 1,513.68% | 95.09M 64.90% | |
debt repayment | -874K - | -1.66M 90.39% | |||||
common stock issued | 72K - | 208.52M 289,506.94% | 96.76M 53.60% | 654K 99.32% | 493K 24.62% | ||
common stock repurchased | |||||||
dividends paid | |||||||
other financing activites | 1.46M - | 1.75M 19.40% | 85.90M 4,814.02% | 327K 99.62% | |||
net cash used provided by financing activities | 1.46M - | 946K 35.38% | 292.75M 30,846.09% | 97.09M 66.84% | 654K 99.33% | 493K 24.62% | |
effect of forex changes on cash | 5.17M - | ||||||
net change in cash | -1.01M - | -1.26M 24.60% | 58.57M 4,744.65% | 49.91M 14.78% | -14.15M 128.35% | -5.38M 61.97% | |
cash at beginning of period | 4.33M - | 3.32M 23.38% | 2.06M 38.02% | 60.63M 2,848.69% | 110.54M 82.33% | 95.97M 13.18% | |
cash at end of period | 3.32M - | 2.06M 38.02% | 60.63M 2,848.69% | 110.54M 82.33% | 96.39M 12.80% | 90.58M 6.02% | |
operating cash flow | -4.48M - | -3.71M 17.18% | -24.11M 549.42% | -43.10M 78.73% | -72.47M 68.15% | -100.75M 39.03% | |
capital expenditure | -2.32M - | -1.57M 32.20% | -1.14M 27.46% | -304K 73.36% | |||
free cash flow | -4.48M - | -3.71M 17.18% | -26.43M 611.90% | -44.67M 69.00% | -73.61M 64.78% | -101.06M 37.29% |
All numbers in USD (except ratios and percentages)